Novavax is developing NVX-CoV2373, a new vaccine for SARS-CoV-2, in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI). To rapidly advance the program and deliver experimental vaccine doses as soon as possible, Novavax is..
Relevance: 7.328481